Effects of CAF-Derived MicroRNA on Tumor Biology and Clinical Applications

Related Experiment Video

Updated: Oct 30, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

Xu Wang1,2,3, Xin Wang1,2,3, Midie Xu1,2

  • 1Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai 200032, China.

Cancers
|July 2, 2021
PubMed

Insights

Cancer-associated fibroblasts (CAFs) influence tumor progression and chemoresistance. CAF-derived microRNAs (miRNAs) are key regulators, offering potential as diagnostic biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment (TME).
  • CAFs significantly impact tumor cell growth, invasion, migration, and chemoresistance.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.

Purpose of the Study:

  • To explore the regulatory function of CAF-derived miRNAs in tumor progression and chemoresistance.
  • To understand the molecular mechanisms underlying CAF activation and function.
  • To identify potential clinical applications of CAF-derived miRNAs.

Main Methods:

  • Review of existing literature on miRNA dysregulation in CAFs.
  • Analysis of differentially expressed miRNAs between normal fibroblasts (NFs) and CAFs.
  • Summarization of the role of CAF-derived miRNAs in fibroblast activation and tumor advancement.

Main Results:

  • Dysregulation of miRNAs in CAFs promotes the conversion of NFs to CAFs.
  • CAF-derived miRNAs enhance the tumor-promoting capacity of CAFs.
  • Specific miRNAs show differential expression between NFs and CAFs.

Conclusions:

  • CAF-derived miRNAs play a crucial role in tumor progression and chemoresistance.
  • These miRNAs represent potential diagnostic and prognostic biomarkers.
  • CAF-derived miRNAs are promising targets for anti-tumor therapeutics.
Keywords:
angiogenesisbiomarkercancer-associated fibroblastschemoresistancemicroRNAtumorigenesis

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

75
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K